跳至主要内容
临床试验/NCT00655902
NCT00655902已完成不适用

Copenhagen Obesity Risk Assessment Study - A Double Blind Randomized Dietary Intervention Study Examining the Effect of a High Intake of Trans Fatty Acids on Abdominal Obesity and Risk Markers of Type 2 Diabetes and Cardiovascular Disease.

University of Copenhagen2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
2
主要终点
change in LDL-cholesterol/LDL-cholesterol ratio

研究概览

简要总结

The aim of the present study is to assess the effect of a high intake of industrially produced trans fatty acids for 16 weeks on abdominal obesity and risk markers of type 2 diabetes and heart disease in healthy, moderately overweight, postmenopausal women.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
45 Years 至 70 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Age 45-70 years
  • BMI 25-32
  • Waist circumference > 80 cm
  • Postmenopausal for at least 1 year

排除标准

  • BP > 160/100 mmHg
  • Fasted blood glucose > 7 mM
  • Fasted LDL-cholesterol > 6 mM
  • Fasted triglycerides > 3 mM
  • Diabetes mellitus or other chronic diseases
  • Current or previous cardiovascular disease
  • Weight change > 3 kg within last 2 months
  • Use of anti-hypertensive drugs
  • Use of statins/fibrates
  • Use of fish oil supplements
  • Hard physical activity > 10 h/week

结局指标

主要结局

change in LDL-cholesterol/LDL-cholesterol ratio

时间窗: week 0, 8, 16 and 28

Change in Liver fat measured by MR-S

时间窗: week 0, 16 and 28

Change in Insulin sensitivity (ISI composite) from 3h OGTT

时间窗: week 0, 8, 16 and 28

次要结局

  • Change in Waist circumference(week 0, 8, 16 and 28)
  • Change in Visceral adipose tissue measured by MR(week 0, 16 and 28)
  • Change in Intramuscular fat measured by MR-S (Psoas Major)(week 0, 16 and 28)
  • Change in Body fat percentage measured by DEXA(week 0, 16 and 28)
  • Change in 24h heart rate variability measured by Holter-monitoring(week 0, 16 and 28)
  • Changes in Cytokines in blood(week 0, 8, 16 and 28)
  • Changes in Cytokines in abdominal adipose tissue(week 0, 16 and 28)
  • Changes in Ceramide in abdominal adipose tissue(week 0, 16 and 28)
  • Changes in Metabolomic profile in blood and urine(week 0, 16 and 28)

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验

Copenhagen Obesity Risk Assessment Study | 临床试验